Ipsen Pharma GmbH
Industry / private company
Location:
Ettlingen,
Germany (DE)
ISNI: 0000000405384461
ROR: https://ror.org/02e60zs41
Show on Map:
Integrated Safety Analysis of Telotristat Ethyl in Patients With Carcinoid Heart Disease (2018)
Lapuerta P, Kulke MH, Pavel ME, Biran T, Fleming R, Zacks JS, Hoffmanns P, Warner RRP
Conference contribution
Disease Control in Progressive Pancreatic and Intestinal Neuroendocrine Tumors by Combined Treatment with Lanreotide Autogel and Temozolomide: The SONNET Study (2018)
Pavel ME, Denecke T, Lahner H, Hoersch D, Rinke A, Koch A, Liyanage N, et al.
Conference contribution
Combined lanreotide autogel and temozolomide in progressive neuroendocrine tumours: an interim safety analysis of the SONNET study (2017)
Hoersch D, Raderer M, Lahner H, Rinke A, Denecke T, Koch A, Raspel A, et al.
Conference contribution